These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the cat]. Kaverina NV; Rodionov AP; Berdjajev SJ; Darinskij NW; Sulakvelidze MT; Klemm W Pharmazie; 1985 Dec; 40(12):868-9. PubMed ID: 3841606 [TBL] [Abstract][Full Text] [Related]
7. [Clinico-electrophysiologic studies on the action of the anti-arrhythmic substance 3-carbethoxyamino-5-dimethylamino-acetyl-10,11-dihydro-5H- dibenz[b,f]azepine hydrochloride (Bonnecor, AWD 19-166, GS 015)]. Rostock KJ; Rathgen K; Pfeiffer D; Rostock G Pharmazie; 1985 Dec; 40(12):862-4. PubMed ID: 3841604 [TBL] [Abstract][Full Text] [Related]
8. [New derivatives of 10,11-dihydro-5H-dibenz[b,f]azepine with antiarrhythmic action]. Wunderlich H; Stark A; Carstens E; Lohmann D; Grizenko AN; Skoldinov AP Pharmazie; 1985 Dec; 40(12):827-30. PubMed ID: 4095140 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacologic studies on the effect of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on the vegetative and central nervous system]. Rostock A; Hoffmann W; Ploen U; Bartsch R Pharmazie; 1985 Dec; 40(12):875-8. PubMed ID: 3841610 [TBL] [Abstract][Full Text] [Related]
10. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride]. Femmer K; Poppe H; Heer S; Bartsch R Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597 [TBL] [Abstract][Full Text] [Related]
12. Electrophysiological effects of a new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015) on mammalian myocardium. Nilius B; Schüttler K; Benndorf K; Boldt W Pharmazie; 1985 Dec; 40(12):847-51. PubMed ID: 3841600 [TBL] [Abstract][Full Text] [Related]
13. [Summarized presentation of studies on the toxicology of 3-carbethoxyamino-5-dimethylamino-acetyl-10,11- dihydrobenz[b,f]azepine hydrochloride (Bonnecor, GS 015, AWD 19-166)]. Nürnberger H; Stade K Pharmazie; 1985 Dec; 40(12):871-3. PubMed ID: 3841608 [TBL] [Abstract][Full Text] [Related]
14. Inotropic effects of the antiarrhythmic compound Bonnecor (AWD 19-166, GS 015). Nilius B; Schumann M Pharmazie; 1985 Dec; 40(12):854. PubMed ID: 3841601 [TBL] [Abstract][Full Text] [Related]
15. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines]. Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological research on bonnecor and its metabolites]. Poppe H; Heer S; Barch R Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics and metabolism of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the rat]. Klemm W; Morgenroth U; Joram U; Rodionov AP Pharmazie; 1985 Dec; 40(12):864-7. PubMed ID: 3841605 [TBL] [Abstract][Full Text] [Related]
18. Electrical effects of the new antiarrhythmic compound Bonnecor (AWD 19-166, GS 015) under arrhythmogenic conditions. Nilius B Pharmazie; 1985 Dec; 40(12):855-6. PubMed ID: 3841602 [TBL] [Abstract][Full Text] [Related]
19. Use dependent depression of fast sodium current in heart muscle by the new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015). Nilius B; Benndorf K; Schüttler K; Boldt W Pharmazie; 1985 Dec; 40(12):852-4. PubMed ID: 2419929 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]